A

half dozen U.S. senators want the U.S. Army to hold a public hearing to explore the controversy over the pricing of a Zika virus vaccine that Sanofi is developing with taxpayer dollars.

In a letter sent on Monday to Acting U.S. Secretary of the Army Robert Speer, the lawmakers expressed concerns that a vaccine would not be “accessible and affordable” for many Americans, since the company may win an exclusive license to develop the technology and have “monopolistic” rights through 2036.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Interesting phrase. The ‘reasonable pricing’ was removed – “over concerns that such clauses would be seen by industry as a “restraint” on new product development.” One could wonder how such a concern surfaced – or who surfaced it?

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.